Journal of Shanghai Jiao Tong University (Medical Science) >

2022 , Vol. 42 >Issue 1: 63 - 69

DOI: https://doi.org/10.3969/j.issn.1674-8115.2022.01.009

Clinical research

Molecular genetic diagnosis of 9 cases with 46,XY complete gonadal dysgenesis

  • Haicheng WANG ,
  • Yu LIU ,
  • Hui YE ,
  • Lin NI ,
  • Ying CAO ,
  • Yunlong SUN ,
  • Bing XIAO ,
  • Caixia MA ,
  • Lifang TANG
Expand
  • 1.Department of Pediatric Endocrinology and Genetic Metabolism, Shanghai Institute for Pediatric Research, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
    2.Department of Pediatrics, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai 201700, China
TANG Lifang, E-mail: tanglifang1119@126.com.

Received date: 2021-07-29

  Online published: 2022-01-28

Supported by

National Natural Science Foundation of China(81401193);Municipal Natural Science Foundation of Shanghai(19ZR1442100)

Fold

Abstract

Objective

·To identify the genetic causes of 9 patients with 46,XY complete gonadal dysgenesis (CGD) .

Methods

·The genetic variations of 9 patients with 46,XY CGD were analyzed by combining SRY mutation screening, next generation sequencing (NGS) and chromosome microarray (CMA).

Results

·SRY mutations were identified in 4 of nine 46,XY CGD probands, including 2 patients with novel SRY gene pathogenic/likely pathogenic mutations, namely SRY deletion and c.208T>C (p.Trp70Arg) missense variation, and 2 patients with reported SRY pathogenic mutation, namely c.169C>T(p.Gln57X) and c.264dup(p.Glu89fs*15). One patient was identified with a heterozygous mutation in MAP3K1 gene c.1016G>A (p.Arg339Gln) by NGS, which was likely pathogenic mutation. In addition, CMA analysis and NGS found no pathogenic copy number variations (CNVs) in other 2 sporadic patients. Whole exome sequencing (WES) was performed on the younger of two sisters, whose parents were consanguineous marriage, filtered homozygous variants in the homozygous regions, no specific deleterious variants or likely variants associated with sexual development were found. CNVs analysis found an approximate 14 kb homozygous deletion in intron 2 of DMRT1 gene in both sister cases (Chr9: 866, 388-880, 086, hg19), and PCR sequencing with amplified spanned the junction revealed that healthy parents were heterozygous deletion carriers. Then PhastCons software was used to analyze the conserved fragments of the deletion intron sequences and two conserved non-coding elements (CNEs) were found.

Conclusion

·SRY mutation was the frequent cause accounted for 46,XY CGD, and 2 novel pathogenic mutations in SRY gene were found. The 14 kb homozygous deletion in intron 2 of DMRT1 might be candidate pathogenic mutation for the sister patients. Stepwise analysis of genetic causes of 46,XY CGD patients might help to fully learn about the molecular changes in these patients.

Key words： 46,XY complete gonadal dysgenesis; disorders of sex development; SRY gene; MAP3K1 gene; next generation sequencing

Cite this article

Haicheng WANG , Yu LIU , Hui YE , Lin NI , Ying CAO , Yunlong SUN , Bing XIAO , Caixia MA , Lifang TANG . Molecular genetic diagnosis of 9 cases with 46,XY complete gonadal dysgenesis[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022 , 42(1) : 63 -69 . DOI: 10.3969/j.issn.1674-8115.2022.01.009

References

1 BASHAMBOO A, MCELREAVEY K. Gene mutations associated with anomalies of human gonad formation[J]. Sex Dev, 2013, 7: 126-146.
2 BAXTER R M, ARBOLEDA V A, LEE H, et al. Exome sequencing for the diagnosis of 46,XY disorders of sex development[J]. J Clin Endocrinol Metab, 2015, 100(2): E333-344.
3 EGGERS S, SADEDIN S, BERGEN JAVAN DEN, et al. Disorders of sex development: insights from targeted gene sequencing of a large international patient cohort[J]. Genome Biol, 2016, 17(1): 243.
4 ONO M, HARLEY V R. Disorders of sex development: new genes, new concepts[J]. Nat Rev Endocrinol, 2013, 9(2): 79-91.
5 HUGHES I A. Disorders of sex development: a new definition and classification[J]. Best Pract Res Clin Endocrinol Metab, 2008, 22(1): 119-134.
6 GRANADOS A, ALANIZ V I, MOHNACH L, et al. MAP3K1-related gonadal dysgenesis: six new cases and review of the literature[J]. Am J Med Genet C Semin Med Genet, 2017, 175(2): 253-259.
7 ARBOLEDA V A, LEE H, SáNCHEZ F J, et al. Targeted massively parallel sequencing provides comprehensive genetic diagnosis for patients with disorders of sex development[J]. Clin Genet, 2013, 83(1): 35-43.
8 DONG Y, YI Y, YAO H, et al. Targeted next-generation sequencing identification of mutations in patients with disorders of sex development[J]. BMC Med Genet, 2016, 17: 23.
9 KIM J H, KANG E, HEO S H, et al. Diagnostic yield of targeted gene panel sequencing to identify the genetic etiology of disorders of sex development[J]. Mol Cell Endocrinol, 2017, 444: 19-25.
10 YU B Q, LIU Z X, GAO Y J, et al. Prevalence of gene mutations in a Chinese 46,XY disorders of sex development cohort detected by targeted next-generation sequencing[J]. Asian J Androl, 2021, 23(1): 69-73.
11 TANNOUR-LOUET M, HAN S, CORBETT S T, et al. Identification of de novo copy number variants associated with human disorders of sexual development[J]. PLoS One, 2010, 5(10): e15392.
12 LIAO X, LIANG D, LI Y, et al. Mutation analysis of the SRY, NR5A1, and DHH genes in six Chinese 46,XY women[J]. J Matern Fetal Neonatal Med, 2011, 24(6): 863-866.
13 XIE S, LAN Z, QU N, et al. Detection of truncated dystrophin lacking the C-terminal domain in a Chinese pedigree by next-generation sequencing[J]. Gene, 2012, 499(1): 139-142.
14 SUN Y, HU G, LIU H, et al. Further delineation of the phenotype of truncating KMT2A mutations: the extended Wiedemann-Steiner syndrome[J]. Am J Med Genet A, 2017, 173(2): 510-514.
15 RICHARDS S, AZIZ N, BALE S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424.
16 YANG Z, YE L, WANG W, et al. 17β-Hydroxysteroid dehydrogenase 3 deficiency: three case reports and a systematic review[J]. J Steroid Biochem Mol Biol, 2017, 174: 141-145.
17 PEARLMAN A, LOKE J, LE CAIGNEC C, et al. Mutations in MAP3K1 cause 46,XY disorders of sex development and implicate a common signal transduction pathway in human testis determination[J]. Am J Hum Genet, 2010, 87(6): 898-904.
18 BARBARO M, BALSAMO A, ANDERLID B M, et al. Characterization of deletions at 9p affecting the candidate regions for sex reversal and deletion 9p syndrome by MLPA[J]. Eur J Hum Genet, 2009, 17(11): 1439-1447.
19 LEDIG S, HIORT O, SCHERER G, et al. Array-CGH analysis in patients with syndromic and non-syndromic XY gonadal dysgenesis: evaluation of array CGH as diagnostic tool and search for new candidate loci[J]. Hum Reprod, 2010, 25(10): 2637-2646.
20 MELLO M P, COELI F B, ASSUMP??O J G, et al. Novel DMRT1 3′UTR+11insT mutation associated to XY partial gonadal dysgenesis[J]. Arq Bras Endocrinol Metabol, 2010, 54(8): 749-753.
21 PAGANI F, BURATTI E, STUANI C, et al. A new type of mutation causes a splicing defect in ATM[J]. Nat Genet, 2002, 30(4): 426-429.
22 KUILENBURG A BVAN, MEIJER J, MUL A N, et al. Intragenic deletions and a deep intronic mutation affecting pre-mRNA splicing in the dihydropyrimidine dehydrogenase gene as novel mechanisms causing 5-fluorouracil toxicity[J]. Hum Genet, 2010, 128(5): 529-538.
23 LISKA F, SNAJDR P, SEDOVá L, et al. Deletion of a conserved noncoding sequence in Plzf intron leads to Plzf down-regulation in limb bud and polydactyly in the rat[J]. Dev Dyn, 2009, 238(3): 673-684.
Options
Outlines

/

〈 〉